Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Jefferies Downgrades Reneo Pharmaceuticals to Hold, Lowers Price Target to $1.8

Author: Benzinga Newsdesk | December 15, 2023 06:53am
Jefferies analyst Eun Yang downgrades Reneo Pharmaceuticals (NASDAQ:RPHM) from Buy to Hold and lowers the price target from $17 to $1.8.

Posted In: RPHM